Vitamin D Testing and Supplementation: What the Evidence Says

Vitamin D testing has become a near-default part of routine lab panels, and high-dose supplementation is widely recommended for a huge range of conditions, often on the basis of earlier observational research that has not consistently held up in the more rigorous randomized trials conducted since. The current evidence supports a more targeted approach than routine testing and blanket high-dose supplementation for everyone.

What the USPSTF actually recommends

The US Preventive Services Task Force has reviewed the evidence on routine vitamin D screening in asymptomatic, average-risk adults and found insufficient evidence to recommend it as a universal screening test. This is a meaningfully different position than the way vitamin D testing gets treated in practice, often included by default in broad lab panels regardless of symptoms or risk factors.

This does not mean vitamin D testing is never useful. It means routine, blanket testing for everyone is not currently evidence-supported the way, for example, cholesterol screening is. Testing is reasonable and appropriate for people with specific risk factors or relevant symptoms.

Who actually benefits from testing

Meaningful risk factors for vitamin D deficiency include limited sun exposure, darker skin (which reduces vitamin D synthesis from sunlight), obesity, malabsorption conditions (such as celiac disease or inflammatory bowel disease), older age, and living at higher latitudes with less year-round sun exposure. For people with one or more of these factors, or symptoms that could relate to deficiency (bone pain, muscle weakness), testing has a clearer rationale.

What large trials have found about high-dose supplementation

Earlier optimism about vitamin D, based substantially on observational studies linking low vitamin D to various conditions, has not been consistently confirmed by more rigorous randomized controlled trials. The VITAL trial, a large randomized trial specifically designed to test this question, found that vitamin D supplementation in adults without confirmed deficiency did not significantly reduce fracture risk. Similar patterns have emerged across trials looking at cardiovascular disease and cancer prevention, where observational associations did not translate into a clear benefit from supplementation in randomized trials.

This does not mean vitamin D is unimportant. It plays a real, established role in bone health and calcium regulation, particularly in people who are actually deficient. It means the evidence does not support high-dose supplementation as a broad preventive intervention for the general population without confirmed deficiency.

A reasonable approach

For most adults without specific risk factors, a general maintenance dose, commonly in the range of 600 to 2000 IU daily depending on age and guideline source, is a reasonable, low-risk approach without needing a test first. For people with risk factors for deficiency or relevant symptoms, testing to confirm an actual deficient level, and then treating with a therapeutic dose guided by that result, is the more evidence-supported path than assuming a high dose is beneficial regardless of your actual level.

If you are unsure whether testing makes sense for you specifically, that is a reasonable question to bring to your next visit. Most major insurance plans, including Medicare, cover vitamin D testing when there is a documented clinical reason for it.